TY - JOUR
T1 - The importance of low-density lipoprotein cholesterol measurement and control as performance measures
T2 - A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology
AU - Virani, Salim S.
AU - Aspry, Karen
AU - Dixon, Dave L.
AU - Ferdinand, Keith C.
AU - Heidenreich, Paul A.
AU - Jackson, Elizabeth J.
AU - Jacobson, Terry A.
AU - McAlister, Janice L.
AU - Neff, David R.
AU - Gulati, Martha
AU - Ballantyne, Christie M.
N1 - Publisher Copyright:
© 2023
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Despite the established role of low-density lipoprotein cholesterol (LDL-C) as a major risk factor for cardiovascular disease (CVD), and the persistence of CVD as the leading cause of morbidity and mortality in the United States, national quality assurance metrics no longer include LDL-C measurement as a required performance metric. This clinical perspective reviews the history of LDL-C as a quality and performance metric and the events that led to its replacement. It also presents patient, healthcare provider, and health system rationales for re-establishing LDL-C measurement as a performance measure to improve cholesterol control in high-risk groups and to stem the rising tide of CVD morbidity and mortality, cardiovascular care disparities, and related healthcare costs.
AB - Despite the established role of low-density lipoprotein cholesterol (LDL-C) as a major risk factor for cardiovascular disease (CVD), and the persistence of CVD as the leading cause of morbidity and mortality in the United States, national quality assurance metrics no longer include LDL-C measurement as a required performance metric. This clinical perspective reviews the history of LDL-C as a quality and performance metric and the events that led to its replacement. It also presents patient, healthcare provider, and health system rationales for re-establishing LDL-C measurement as a performance measure to improve cholesterol control in high-risk groups and to stem the rising tide of CVD morbidity and mortality, cardiovascular care disparities, and related healthcare costs.
KW - Blood pressure
KW - Cardiovascular disease
KW - LDL Cholesterol
KW - Lipoprotein modifying
KW - Risk factors
KW - Statins
UR - http://www.scopus.com/inward/record.url?scp=85151044489&partnerID=8YFLogxK
U2 - 10.1016/j.jacl.2023.02.003
DO - 10.1016/j.jacl.2023.02.003
M3 - Article
C2 - 36965958
AN - SCOPUS:85151044489
SN - 1933-2874
VL - 17
SP - 208
EP - 218
JO - Journal of Clinical Lipidology
JF - Journal of Clinical Lipidology
IS - 2
ER -
